ArticleGut2022

Pan-ERBB kinase inhibition augments CDK4/6 inhibitor efficacy in oesophageal squamous cell carcinoma.

Jin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.